(2E)-1-(3-bromophenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Silica gel 60 G/F254, 500 g

(4-Fluoro-2-(hydroxymethyl)phenyl)boronic acid, 95.0%, 250mg

METHYL (S)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-((S)-2-OXOPIPERIDIN-3-YL)PROPANOATE, 95%, 250mg

(2-(1H-indol-3-yl)acetyl)-L-leucine, 98%, 250mg

4-Bromo-2-hydroxybenzonitrile>98.0%(GC)1g

Récipient de réaction à bride plate, cylindrique, gradué, avec enveloppe de trempe et de vide et vanne de vidange, DN 150, 250 ml, 120 mm, 1 pièce

1-(Hydroxymethyl)pyrrolidin-2-one, 97%, 100mg

2-BROMO-3-FLUORO-5-(TRIFLUOROMETHYL)PYRIDINE, 95%, 250mg

Methyl 5-bromo-4-fluoro-2-iodobenzoate, 98%, 500mg

2-BROMO-5,8-DIOXASPIRO[3.4]OCTANE, 95.0%, 10g

tert-Butyl 3,3-dimethylpiperazine-1-carboxylate hydrochloride, 97%, 100mg

3-Methylene-2-norbornanone, 98% (stabilized with MEHQ), 5g